Clinical Outcomes of rhBMP-2-Loaded Collagen Sponge for Alveolar Ridge Preservation: A Pilot Study.

IF 2.1 Q1 Dentistry
Peungchaleoy Thammanichanon, Warisara Ouyyamwongs, Katanchalee Mai-Ngam, Pawornwan Rittipakorn
{"title":"Clinical Outcomes of rhBMP-2-Loaded Collagen Sponge for Alveolar Ridge Preservation: A Pilot Study.","authors":"Peungchaleoy Thammanichanon, Warisara Ouyyamwongs, Katanchalee Mai-Ngam, Pawornwan Rittipakorn","doi":"10.1055/s-0045-1810610","DOIUrl":null,"url":null,"abstract":"<p><p>Alveolar bone resorption following tooth extraction poses a significant clinical challenge. While various ridge preservation techniques exist, limitations remain. Recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered via an absorbable collagen sponge (ACS) has shown promise in bone augmentation. This pilot randomized controlled trial aimed to evaluate the efficacy of ACS combined with rhBMP-2 for alveolar ridge preservation in maintaining ridge dimensions after tooth extraction.This pilot randomized controlled trial enrolled 11 participants with 16 extraction sites, randomized to either the intervention (ACS/rhBMP-2) or the control (empty socket) group. The <i>in vitro</i> release kinetics of rhBMP-2 from the ACS carrier were measured over 13 days using ELISA (enzyme-linked immunosorbent assay). Clinical procedures involved atraumatic extraction, followed by the placement of ACS/rhBMP-2 in the intervention group. Alveolar ridge dimensions were assessed using cone-beam computed tomography at baseline (T0), and at 4 (T4), 8 (T8), and 12 weeks (T12) post-extraction.Data were presented as mean ± standard deviation. A linear mixed model was used to compare dimensional changes over time between the two groups. A <i>p-</i>value of <0.05 was considered statistically significant.The <i>in vitro</i> assay showed a gradual, sustained release of rhBMP-2 from the ACS, with a cumulative release of 7.28% (117 ± 5.18 µg) over 13 days. No postoperative complications were observed in any participant. At 12 weeks, the ACS/rhBMP-2 group demonstrated a statistically significant preservation of buccal bone height, with 1.80 mm less vertical reduction compared to the control group. No significant differences were found between groups for palatal/lingual bone reduction or for changes in the overall bucco-lingual ridge width.The application of ACS combined with rhBMP-2 is an effective approach for mitigating buccal bone resorption after tooth extraction. This intervention is clinically significant as it preserves critical buccal plate height, potentially reducing the need for further augmentation prior to implant placement, even though it does not prevent overall ridge width collapse.</p>","PeriodicalId":12028,"journal":{"name":"European Journal of Dentistry","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Dentistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0045-1810610","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Dentistry","Score":null,"Total":0}
引用次数: 0

Abstract

Alveolar bone resorption following tooth extraction poses a significant clinical challenge. While various ridge preservation techniques exist, limitations remain. Recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered via an absorbable collagen sponge (ACS) has shown promise in bone augmentation. This pilot randomized controlled trial aimed to evaluate the efficacy of ACS combined with rhBMP-2 for alveolar ridge preservation in maintaining ridge dimensions after tooth extraction.This pilot randomized controlled trial enrolled 11 participants with 16 extraction sites, randomized to either the intervention (ACS/rhBMP-2) or the control (empty socket) group. The in vitro release kinetics of rhBMP-2 from the ACS carrier were measured over 13 days using ELISA (enzyme-linked immunosorbent assay). Clinical procedures involved atraumatic extraction, followed by the placement of ACS/rhBMP-2 in the intervention group. Alveolar ridge dimensions were assessed using cone-beam computed tomography at baseline (T0), and at 4 (T4), 8 (T8), and 12 weeks (T12) post-extraction.Data were presented as mean ± standard deviation. A linear mixed model was used to compare dimensional changes over time between the two groups. A p-value of <0.05 was considered statistically significant.The in vitro assay showed a gradual, sustained release of rhBMP-2 from the ACS, with a cumulative release of 7.28% (117 ± 5.18 µg) over 13 days. No postoperative complications were observed in any participant. At 12 weeks, the ACS/rhBMP-2 group demonstrated a statistically significant preservation of buccal bone height, with 1.80 mm less vertical reduction compared to the control group. No significant differences were found between groups for palatal/lingual bone reduction or for changes in the overall bucco-lingual ridge width.The application of ACS combined with rhBMP-2 is an effective approach for mitigating buccal bone resorption after tooth extraction. This intervention is clinically significant as it preserves critical buccal plate height, potentially reducing the need for further augmentation prior to implant placement, even though it does not prevent overall ridge width collapse.

载bmp -2胶原海绵保存牙槽嵴的临床结果:一项初步研究。
拔牙后牙槽骨吸收是一个重大的临床挑战。虽然存在各种山脊保存技术,但仍然存在局限性。重组人骨形态发生蛋白-2 (rhBMP-2)通过可吸收胶原海绵(ACS)传递,在骨增强中显示出良好的前景。本试验旨在评价ACS联合rhBMP-2在拔牙后牙槽嵴保存中维持牙槽嵴尺寸的疗效。这项试点随机对照试验招募了11名参与者,有16个提取部位,随机分为干预组(ACS/rhBMP-2)和对照组(空套孔组)。采用ELISA(酶联免疫吸附法)测定了13天内rhBMP-2从ACS载体的体外释放动力学。临床程序包括无伤性拔牙,随后在干预组放置ACS/rhBMP-2。在拔牙后基线(T0)、4 (T4)、8 (T8)和12周(T12)使用锥形束计算机断层扫描评估牙槽嵴尺寸。数据以均数±标准差表示。使用线性混合模型来比较两组之间随时间的维度变化。体外实验的p值显示,rhBMP-2从ACS中逐渐持续释放,13天累积释放量为7.28%(117±5.18µg)。所有参与者均未出现术后并发症。在12周时,ACS/rhBMP-2组显示出具有统计学意义的颊骨高度保存,与对照组相比,垂直复位减少1.80 mm。在腭/舌骨复位或颊-舌嵴宽度的总体变化方面,两组间没有发现显著差异。ACS联合rhBMP-2的应用是缓解拔牙后颊骨吸收的有效途径。这种干预在临床上具有重要意义,因为它保留了临界颊板高度,潜在地减少了种植体植入前进一步增加的需要,即使它不能防止整体脊宽塌陷。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Dentistry
European Journal of Dentistry Dentistry-Dentistry (all)
CiteScore
5.10
自引率
0.00%
发文量
161
期刊介绍: The European Journal of Dentistry is the official journal of the Dental Investigations Society, based in Turkey. It is a double-blinded peer-reviewed, Open Access, multi-disciplinary international journal addressing various aspects of dentistry. The journal''s board consists of eminent investigators in dentistry from across the globe and presents an ideal international composition. The journal encourages its authors to submit original investigations, reviews, and reports addressing various divisions of dentistry including oral pathology, prosthodontics, endodontics, orthodontics etc. It is available both online and in print.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信